Sort
53,477 grants matching “addiction”
Pharmacogenetics of Oxycodone, Personalized Care and Persistent Surgical Pain
$445,859Senthilkumar Sadhasivam · Indiana University Indianapolis · R01 · FY2020 · HD
INFORMATION TRANSFER--NEUROBIOLOGY OF ALCOHOLISM
$445,850Amethyst Technologies, Inc. · R44 · FY2000 · AA
University of Washington Significant Opportunities in Addiction Research (UW-SOAR) Neuroscience Doctoral Readiness Program
$445,812Susan Marie Ferguson · University Of Washington · R25 · FY2024 · DA
University of Washington Significant Opportunities in Addiction Research (UW-SOAR) Neuroscience Doctoral Readiness Program
$445,812Susan Marie Ferguson · University Of Washington · R25 · FY2023 · DA
HUMAN GENETIC VARIATION IN SMOKING AND ADDICTION RISK
$445,779Nancy L Saccone · Washington University · R01 · FY2009 · DA
COUNSELING CONDITONS FOR THRICE WEEKLY BUP IN A PCC
$445,773Yale University · R01 · FY2003 · DA
Conformation-Selectivity Relations of Opioid Peptides
$445,759University Of Michigan At Ann Arbor · R01 · FY2003 · DA
GPR88 Agonist for Alcoholism Treatment
$445,742Chunyang Jin · Research Triangle Institute · R01 · FY2018 · AA
Mechanisms of Synaptic Plasticity in the Hippocampus
$445,730Robert C Malenka · Stanford University · R01 · FY2012 · MH
Cocaine Use and Monoamine Function
$445,701Leonard L Howell · Emory University · R01 · FY2011 · DA
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling
$445,606Sergey G Khasabov · University Of Minnesota · R01 · FY2025 · CA
RCMI Administrative Core
$445,574Ezemenari M Obasi · University Of Houston · U54 · FY2021 · MD
Pharmacology and Neuroscience of Drug Abuse
$445,570Hazel H Szeto · Weill Medical Coll Of Cornell Univ · T32 · FY2010 · DA
Training Program: Drugs of Abuse & Related Neuropeptides
$445,539Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2024 · DA
Proteomic Biosignatures of Chronic Drug Exposure
$445,531Howard Schulman · Caprion Proteomics Usa, Llc · R21 · FY2010 · DA
Incubated drug-craving and neurochemical interactions
$445,433Karen Kathleen Szumlinski · University Of California Santa Barbara · R01 · FY2021 · DA
Role of CD36 and diet-derived fatty acids in breast cancer
$445,431Manabu Kurokawa · Kent State University · R15 · FY2021 · CA
Human Clinical Pharmacology of Emerging Drugs of Abuse (Club Drugs)
$445,391Roland R Griffiths · Johns Hopkins University · R01 · FY2010 · DA
HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial New Mexico Site
$445,388Lawrence M Leeman · University Of New Mexico Health Scis Ctr · UG1 · FY2021 · HD
Prescribers, Pharmacists, & the Opioid Dilemma: a Multi-Site Qualitative Study
$445,367Mark J. Edlund · Research Triangle Institute · R01 · FY2015 · DA
Molecular Studies of Cocaine Action in Brain
$445,324Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DA
Neuroscience Training in Drug Abuse Research
$445,309Paul G Mermelstein · University Of Minnesota · T32 · FY2017 · DA
Proteomic Biosignatures of Chronic Drug Exposure
$445,227Howard Schulman · Caprion Proteomics Usa, Llc · R21 · FY2009 · DA
Pharmacologic Approaches to Prescription Opioid Addiction and Relapse Prevention
$445,211Jack Bergman · Mclean Hospital · R01 · FY2018 · DA
Multigenerational Epigenetic Effects of Cannabis Exposure
$445,208Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · DA